News | Artificial Intelligence | June 25, 2021

How AI is Helping the Fight Against Breast Cancer

New technology helps doctors read mammograms faster, and with greater accuracy, which can reduce false positives for women

Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health.

June 25, 2021 — Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health. Recently, Randy Hicks, M.D., MBA, Co-Owner and CEO of Regional Medical Imaging (RMI) in Michigan, participated in a nationwide satellite media tour to discuss how new technology is helping the fight against breast cancer.

The COVID-19 pandemic brought routine health screenings, such as mammograms, to a screeching halt, declining up to 92% in some areas last year, according to a study in the Journal of the American College of Radiology. Now, with Americans getting vaccinated and infection rates decreasing around the country, many women are playing catch-up on these vital health screenings, which leads to another issue — a drastic increase in workload for doctors, who must face a surge of patients who need to be screened.

Fortunately, an innovative new tool is available to help clinicians cope with this sudden demand, which at the same time provides them a higher degree of accuracy than ever before. ProFound AI uses the latest in deep-learning artificial intelligence (AI) and is clinically proven to help radiologists read mammograms more than 50% faster - and with more accuracy - while also reducing false positives and unnecessary callbacks, which can be stressful for women.

ProFound AI was the first 3D tomosynthesis software using AI to be cleared by the FDA. A video accompanying this announcement is available here: https://youtu.be/7nWf973J1ww.

For more information: icadmed.com 

Related Content

Videos | Artificial Intelligence | July 22, 2021
This is an overview of trends and technologies in radiology...
An example of Viz.AI's pulmonary embolism AI application and mobile alert to the physician on-call. Viz.AI and Avicenna.AI Partner to Launch Artificial Intelligence Care Coordination for Pulmonary Embolism and Aortic Disease

An example of Viz.AI's pulmonary embolism AI application and mobile alert to the physician on-call. 

News | July 21, 2021
July 21, 2021 — Artificial int...
Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
Artificial intelligence-powered diagnostic tool spots asymptomatic prostate cancer in seconds

(L-R) Associate Professor Peter Brotchie (St Vincent's), Dr Ruwan Tennakoon (RMIT), Professor John Thangarajah (RMIT), Dr Mark Page (St Vincent's). Image courtesy of St Vincent's Hospital Melbourne

News | Prostate Cancer | July 19, 2021
July 19, 2021 — Prostate cancer is the most diagnosed
Volpara now holds 98 granted patents across 27 countries
News | Breast Imaging | July 16, 2021
July 16, 2021 — Volpara has recently been granted another patent by the...
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
Interviews with the 1,000 at-risk patients also led to some interesting conclusions, Fine said. Even in the early days of 3D mammography, most women interviewed had at least heard about the technology.

Getty Images

News | Mammography | July 15, 2021
July 15, 2021 —  For any type of diagnostic test, technology that helps improve the reliability of test results is a
The Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR), and the Medical Image Computing and Computer Assisted Interventions (MICCAI) society have announced the launch of the 10th annual Brain Tumor Segmentation (BraTS) challenge

Getty Images

News | RSNA | July 14, 2021
July 14, 2021 — The Radiological Society of North America (...
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...